Left ventricular assist devices (LVAD) have revolutionized the management of advanced
heart failure. However, complications rates remain high, among which hemorrhagic and …

Life expectancy of patients with a durable, continuous-flow left ventricular assist device (CF-
LVAD) continues to increase. Despite significant improvements in the delivery of care for …

Pregnancy after thoracic organ transplantation is feasible for select individuals but requires
multidisciplinary subspecialty care. Key components for a successful pregnancy after lung or …

DISCUSSION Pump thrombosis occurring at any level is associated with significant
morbidity. Outflow graft thrombus can be treated medically, surgically, and rarely with …

Background Heart failure (HF) is a significant cause of mortality in children and therefore
there is interest in understanding the optimal way to support these children with Ventricular …

The evolution of devices for mechanical circulatory support (MCS), including ventricular
assist devices (VADs) for patients with heart failure and extracorporeal membrane …

Pump‐induced thrombosis continues to be a major complication of continuous‐flow left
ventricular assist devices (CF‐LVADs), which increases the risks of thromboembolic stroke …

Ventricular assist devices (VAD) are used more in children. Safe and effective
anticoagulation is required for successful management of children supported with ventricular …

Ventricular assist devices (VADs) have played an important role in altering the natural
history of end-stage heart failure. Low-grade hemolysis has been traditionally described in …

Coronavirus disease (COVID-19) can cause circulatory shock refractory to medical therapy.
Such patients can be managed with mechanical circulatory support (MCS) devices like …